China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
Release time：2024-05-21 17:07:42 Source：World Window news portal
-
Contact Us
- Home
- News
- People
- In-depth
- ACWF
- 2023 Women Science and Technology Innovation Pioneer...
- People Enjoy Blooming Tulips in Jinan, East...
- Flowers Bloom Across China in Spring
China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial
September 1, 2022 |
| A nurse shows human papillomavirus (HPV) vaccines developed by Chinese researchers at the provincial Maternity and Child Healthcare Hospital in Wuhan, central China's Hubei Province, May 18, 2020. [Xinhua/Xiong Qi] |
BEIJING, Aug. 30 (Xinhua) — A recent study has found that China's first self-developed HPV vaccine Cecolin can offer women adults full immunity against two types of human papillomavirus (HPV).
A group of Chinese researchers analyzed data from 66-month follow-up visits as a part of the bivalent vaccine's Phase 3 clinical trial and found that its efficacy against high-grade genital lesions, typical symptoms of cervical cancer, reached 100 percent.
Furthermore, the E coli-produced HPV 16/18 recombinant vaccine realized a 97 percent efficacy against persistent HPV infections, according to the study published in the journal Lancet Infectious Diseases.
The clinical trial included 7,372 healthy women aged 18 to 45, with 3,689 in the vaccinated group and 3,683 in the control group. The cumulative incidence in the vaccinated group was noticeably lower than that in the control group, according to the study.
Cecolin is jointly developed by Xiamen University and Xiamen Innovax, making China the third country in the world to attain an independent cervical cancer vaccine supply after the United States and the United Kingdom. It earned the World Health Organization Prequalification in October 2021.
(Source: Xinhua)
32.3KPlease understand that womenofchina.cn,a non-profit, information-communication website, cannot reach every writer before using articles and images. For copyright issues, please contact us by emailing: [email protected]. The articles published and opinions expressed on this website represent the opinions of writers and are not necessarily shared by womenofchina.cn.
Comments
Magazines
Projects
Photos
Special Coverage
- Previous：A warrant for Netanyahu’s arrest was requested. But no decision was made about whether to issue it
- Next：Rangers are undefeated at .500 to keep World Series champs from a losing record with Bochy
Related articles
- Justin Timberlake set to bring his The Forget Tomorrow World Tour to Australia in 2025
- (W.E. Talk) Tamara Prosic: How China and the World Benefit from Collectivism
- World Insights: Strong Mideast rapprochement signals changing regional order
- Full Text of President Xi Jinping's 2024 New Year Message
- The government wants to buy their flood
- UN chief applauds formation of transitional council in Haiti
- Shanghai real estate company faces $1.2 mln fines for multiple violations
- Chinese women's national football team seeks head coach
- Baby Reindeer's real
- To invest in China is to win the future: spokesperson
- Sweden beats France, Britain relegated after losing to Norway at hockey worlds
- Trade fair strengthens win
- Landmark loss and damage fund approved as UN climate conference closes in Egypt
- Ecuador embroiled in diplomatic backlash after police break into Mexican embassy
- US overdose deaths dropped in 2023, the first time since 2018
- China launches satellite to monitor marine, space environments
- China calls for efforts to promote Colombia's national development
- China launches global consumption event series at heavyweight expo
- Mystery artist who erected signs comparing pothole
- Xi Focus: Xi's 2024 New Year Message Highlights Confidence, People, Global Vision
Random recommendation
- Copyright © 2024 Powered by China's First Domestic HPV Vaccine Shows 100 Pct Efficacy in Clinical Trial ,World Window news portal sitemap